Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial.

Simpson EL, Silverberg JI, Worm M, Honari G, Masuda K, Syguła E, Schuttelaar MLA, Mortensen E, Laws E, Akinlade B, Patel N, Maloney J, Paleczny H, Delevry D, Xiao J, Dubost-Brama A, Bansal A

Open source

DOI
10.1016/j.jaad.2023.12.066
Published
2024 Jun
Container
Journal of the American Academy of Dermatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaad.2023.12.066,
  title = {Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial.},
  author = {Simpson EL and Silverberg JI and Worm M and Honari G and Masuda K and Syguła E and Schuttelaar MLA and Mortensen E and Laws E and Akinlade B and Patel N and Maloney J and Paleczny H and Delevry D and Xiao J and Dubost-Brama A and Bansal A},
  year = {2024},
  journal = {Journal of the American Academy of Dermatology},
  doi = {10.1016/j.jaad.2023.12.066},
  url = {https://doi.org/10.1016/j.jaad.2023.12.066}
}

RIS

TY  - JOUR
TI  - Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial.
AU  - Simpson EL
AU  - Silverberg JI
AU  - Worm M
AU  - Honari G
AU  - Masuda K
AU  - Syguła E
AU  - Schuttelaar MLA
AU  - Mortensen E
AU  - Laws E
AU  - Akinlade B
AU  - Patel N
AU  - Maloney J
AU  - Paleczny H
AU  - Delevry D
AU  - Xiao J
AU  - Dubost-Brama A
AU  - Bansal A
PY  - 2024
JO  - Journal of the American Academy of Dermatology
DO  - 10.1016/j.jaad.2023.12.066
UR  - https://doi.org/10.1016/j.jaad.2023.12.066
ER  - 

APA

EL, S., JI, S., M, W., G, H., K, M., E, S., MLA, S., E, M., E, L., B, A., N, P., J, M., H, P., D, D., J, X., A, D., & A, B. (2024). Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial.. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2023.12.066

Source records